title: Protection against Fasciola gigantica using paramyosin antigen as a candidate for vaccine production.
abstract: Yet no vaccine to protect ruminants against liver fluke infection has been commercialized. In an attempt to develop a suitable vaccine against Fasciola gigantica (F. gigantica) infection in rabbits, using 97 kDa Pmy antigen. It was found that, the mean worm burdens and bile egg count after challenge were reduced significantly by 58.40 and 61.40%, respectively. On the other hand, immunization of rabbits with Pmy induced a significant expression of humoral antibodies (IgM, total IgG, IgG1, IgG2 and IgG4) and different cytokines (IL-6, IL-10, L-12 and TNF-alpha). Among Ig isotypes, IgG2 and IgG4 were most dominant Post-infection (PI) while, recording a low IgG1 level. The dominance of IgG2 and IgG4 suggested late T helper1 (Th1) involvement in rabbit's cellular response. While, the low IgG1 level suggested Th2 response to adult F. gigantica worm Pmy. Among all cytokines, IL-10 was the highest in rabbits immunized with Pmy PI suggesting also the enhancement of Th2 response. It was clear that the native F. gigantica Pmy is considered as a relevant candidate for vaccination against fascioliasis. Also, these data suggested the immunoprophylactic effect of the native F. gigantica Pmy which is mediated by a mixed Th1/Th2 response.
authors: Department of Zoology, Faculty of Science, Cairo University, Egypt.
authors: H
authors: H
authors: Abou-Elhakam
authors: Theodore Bilharz Research Institute, Giza, Egypt.
authors: I
authors: I
authors: Rabee
authors: Department of Zoology, Faculty of Science, Cairo University, Egypt.
authors: S
authors: S
authors: El Deeb
authors: Department of Zoology, Faculty of Science, Cairo University, Egypt.
authors: A
authors: A
authors: El Amir
mesh_terms: D000818:Animals; D000909:Antibodies, Helminth / Q000097:blood; D000947:Antigens, Helminth / Q000008:administration & dosage / Q000276:immunology*; D016207:Cytokines / Q000097:blood; D004195:Disease Models, Animal; D005209:Fasciola / Q000145:classification / Q000254:growth & development / Q000276:immunology*; D005211:Fascioliasis / Q000097:blood / Q000276:immunology / Q000469:parasitology / Q000517:prevention & control*; D007111:Immunity, Cellular; D056724:Immunity, Humoral; D007114:Immunization; D007273:Injections, Intramuscular; D008297:Male; D016052:Protozoan Vaccines / Q000008:administration & dosage / Q000276:immunology*; D011817:Rabbits; D018417:Th1 Cells / Q000276:immunology / Q000469:parasitology; D018418:Th2 Cells / Q000276:immunology / Q000469:parasitology; D014335:Tropomyosin / Q000008:administration & dosage / Q000276:immunology*
chemical_list: D000909:Antibodies, Helminth; D000947:Antigens, Helminth; D016207:Cytokines; D016052:Protozoan Vaccines; D014335:Tropomyosin